BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 4566290)

  • 1. A comparison of 5-fluorouracil administered by slow infusion and rapid injection.
    Moertel CG; Schutt AJ; Reitemeier RJ; Hahn RG
    Cancer Res; 1972 Dec; 32(12):2717-9. PubMed ID: 4566290
    [No Abstract]   [Full Text] [Related]  

  • 2. A controlled comparison of 5-fluoro-2'-deoxyuridine therapy administered by rapid intravenous injection and by continuous intravenous infusion.
    Moertel CG; Reitemeier RJ; Hahn RG
    Cancer Res; 1967 Mar; 27(3):549-52. PubMed ID: 4225560
    [No Abstract]   [Full Text] [Related]  

  • 3. Pharmacokinetics of 5-fluorouracil administered orally, by rapid intravenous and by slow infusion.
    Fraile RJ; Baker LH; Buroker TR; Horwitz J; Vaitkevicius VK
    Cancer Res; 1980 Jul; 40(7):2223-8. PubMed ID: 7388790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Experience with the treatment of patients with malignant tumors with 5-fluorouracil].
    Milonov BV; Kosarev VA; Nikiforov AM
    Vopr Onkol; 1967; 13(12):55-61. PubMed ID: 5597532
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparison of continuously infused 5-fluorouracil with bolus injection in treatment of patients with colorectal adenocarcinoma.
    Seifert P; Baker LH; Reed ML; Vaitkevicius VK
    Cancer; 1975 Jul; 36(1):123-8. PubMed ID: 1203840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 100% oxygen inhalation and 5-fluorouracil (NSC-19893) therapy for large bowel carcinoma.
    Moertel CG; Schutt AJ; Reitemeier RJ; Hahn RG
    Cancer Chemother Rep; 1974; 58(6):951-2. PubMed ID: 4614903
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of advanced adenocarcinomas of the exocrine pancreas and the gallbladder with 5-fluorouracil, high dose levofolinic acid and oral hydroxyurea on a weekly schedule. Results of a multicenter study of the Southern Italy Oncology Group (G.O.I.M.).
    Gebbia V; Majello E; Testa A; Pezzella G; Giuseppe S; Giotta F; Riccardi F; Fortunato S; Colucci G; Gebbia N
    Cancer; 1996 Sep; 78(6):1300-7. PubMed ID: 8826954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 5-Fluorouracil (NSC-19893) therapy for pancreatic carcinoma: comparison of oral and intravenous routes.
    Stolinsky DC; Pugh RP; Bateman JR
    Cancer Chemother Rep; 1975; 59(5):1031-3. PubMed ID: 1106846
    [No Abstract]   [Full Text] [Related]  

  • 9. 5-fluorouracil intravenous infusion for 48 hours, repeated every two weeks.
    Hill GJ; Grage TB; Wilson W; Ansfield FJ
    J Surg Oncol; 1972; 4(1):60-70. PubMed ID: 5033956
    [No Abstract]   [Full Text] [Related]  

  • 10. A controlled evaluation of 5-fluorouracil utilizing a single injection technique.
    Ahmann DL; Moertel CG; Bisel HF; Hahn RG; Schutt AJ; Dines DE
    Oncology; 1974; 29(2):166-71. PubMed ID: 4836677
    [No Abstract]   [Full Text] [Related]  

  • 11. [Use of 5-fluorouracil chemotherapy in malignant neoplasms of the large intestine].
    Salama A; Cafoncelli A
    Prensa Med Argent; 1965 Oct; 52(36):2294-5. PubMed ID: 5879676
    [No Abstract]   [Full Text] [Related]  

  • 12. [Evaluation of the combination of BCNU, VCR and 5-FU in the treatment of disseminated neoplasms of the large intestine].
    Luporini G; Labianca R; Fraschini P; Tedeschi L
    Minerva Med; 1980 Mar; 71(10):773-9. PubMed ID: 7360363
    [No Abstract]   [Full Text] [Related]  

  • 13. [Cyclophosphamide, methotrexate and 5-fluorouracil (CMF), versus 5-fluorouracil, in carcinoma of the large intestine in an advanced stage].
    Scanni A; Tomirotti M; Biraghi M; Annibali E; Del Bianco S
    Minerva Med; 1980 Mar; 71(10):799-801. PubMed ID: 7360368
    [No Abstract]   [Full Text] [Related]  

  • 14. Long-term, ambulatory, continuous intravenous infusion of 5-fluorouracil for the treatment of metastatic adenocarcinoma in the liver.
    Ausman RK; Caballero GA; Quebbeman E; Ausman DC
    Wis Med J; 1982 Mar; 81(3):25-8. PubMed ID: 7090413
    [No Abstract]   [Full Text] [Related]  

  • 15. High-dose intravenous infusions of 5-fluorouracil for refractory solid tumours-the HI-FU regimen.
    Spiers AS; Kasimis BS; Janis MG
    Clin Oncol; 1980 Mar; 6(1):63-9. PubMed ID: 6154557
    [No Abstract]   [Full Text] [Related]  

  • 16. Experience with ftorafur treatment in breast cancer.
    Karev NI; Blokhina NG; Vozny EK; Pershin MP
    Neoplasma; 1972; 19(4):347-50. PubMed ID: 5054534
    [No Abstract]   [Full Text] [Related]  

  • 17. [The use of 5-fluorouracil in the therapy of some epithelial tumors].
    Traldi A; Morini A
    Minerva Med; 1966 Mar; 57(25):1146-9. PubMed ID: 5932019
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparison of rapid and slow intravenous administration of 5-fluorouracil in treating patients with advanced carcinoma of the large intestine.
    REITEMEIER RJ; MOERTEL CG
    Cancer Chemother Rep; 1962 Dec; 25():87-9. PubMed ID: 13981540
    [No Abstract]   [Full Text] [Related]  

  • 19. [Therapy of advanced tumors with 5-fluoro-uracil].
    Zimmermann G; Boeckl O
    Wien Med Wochenschr; 1969 Sep; 119(37):613-6. PubMed ID: 4187496
    [No Abstract]   [Full Text] [Related]  

  • 20. Palliative treatment of metastasized breast cancer with 5-fluoro-uracil in slow intravenous infusion.
    Huys J; Van Vaerenbergh PM
    J Radiol Electrol Med Nucl; 1967 Nov; 48(11):805-6. PubMed ID: 4173581
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.